Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

Finasteride caused long-term sexual and non-sexual side effects in young men with hair loss.

Curcuma aeruginosa extract combined with minoxidil effectively treats male-pattern baldness.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

Exercise improves insulin sensitivity and hormone regulation in PCOS rats.

Sinapic acid may help hair growth by activating a specific cell pathway.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.

No definitive link between finasteride and male breast cancer, but further research is needed.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

New drug shows promise for better hair growth in baldness treatment.

Recreational drug use can cause misdiagnosed conditions and drug interactions in HIV patients.

Sex hormones affect reproduction, sexual development, and oral health, and it's important for dental practitioners to understand their effects and interactions.

Hair loss in women is often due to hereditary conditions or stress, and while treatments like minoxidil can help, diagnosis and management require medical guidance.

Men over 66 taking medication for prostate enlargement have a higher risk of depression and self-harm, especially in the first 18 months of treatment.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.

Finasteride can cause one-sided breast enlargement, which disappears after stopping the drug.

Future osteoporosis treatments should focus on increasing bone growth, with many promising options available.

Finasteride use linked to increased risk of sexual dysfunction, especially in younger people.

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

Taking 5α-reductase inhibitors with prednisolone can worsen its negative effects on metabolism.

Taking both finasteride and dutasteride for prostate issues may raise the risk of heart problems.

Spironolactone might lower the chance of getting rosacea.

Dutasteride and finasteride have similar effects on prostate cancer risk in BPH patients.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

Taking 5-alpha reductase inhibitors does not increase breast cancer risk in men.

Finasteride and methadone don't increase advanced liver disease risk in HCV+ male veterans.

OTEC power output is higher in summer due to greater temperature differences.

Long-term use of 5α-reductase inhibitors may improve survival in men with kidney cancer.

Finasteride and dutasteride have little effect on Type 2 Diabetes risk.